Hepatoprotective peptides of the drug Laennec

Author:

Torshin Ivan Yu.1ORCID,Gromova Olga A.1ORCID,Tikhonova Olga V.2ORCID,Zgoda Viktor G.2ORCID

Affiliation:

1. Federal Research Center “Informatics and Management”, Russian Academy of Sciences

2. V. N. Orekhovich Research Institute of Biomedical Chemistry

Abstract

Human placenta hydrolysates (HPH) have a pronounced hepatoprotective effect, the molecular mechanisms of which are not well understood. As a result of de novo mass spectrometric sequencing and bioinformatics analysis of peptides, 27 peptides were found in the Laennec HPP preparation, which (1) support inositol phosphate-dependent signaling pathways of hepatocytes, (2) activate the target proteins RARA, AMPK, and (3) inhibit target proteins Notch1, GSK-3, PAK1 and TLR4. By exhibiting anti-inflammatory, antifibrotic, vasodilatory, antiatherosclerotic, and antidiabetic properties, these peptides can make a significant contribution to the hepatoprotective properties of HLP.

Publisher

LLC Global Media Technology

Subject

Gastroenterology,Hepatology

Reference48 articles.

1. Sheka A. C., Adeyi O., Thompson J., Hameed B., Crawford P. A., Ikramuddin S. Nonalcoholic Steatohepatitis: A Review. JAMA. 2020 Mar 24;323(12):1175-1183. doi: 10.1001/jama.2020.2298. PMID: 32207804.

2. Mundi M. S., Velapati S., Patel J., Kellogg T. A., Abu Dayyeh B. K., Hurt R. T. Evolution of NAFLD and Its Management. NutrClinPract. 2020 Feb;35(1):72-84. doi: 10.1002/ncp.10449. PMID: 31840865.

3. Gromova O. A., Torshin I. Yu., Chuchalin A. G., Maksimov V. A. Human placenta hydrolysates: from V. P. Filatov to the present day. Terapevticheskii Arkhiv (Ter. Arkh.). 2022;94(3):434-441. (in Russ.) doi: 10.26442/00403660.2022.03.201408 @@Gromova O. A., Torshin I. Yu., Chuchalin A. G., Maksimov V. A. Gidrolizaty platsenty cheloveka: ot V. P. Filatova do nashikh dnei. Terapevticheskii arkhiv. 2022;94(3):434-441. doi: 10.26442/00403660.2022.03.201408

4. Maksimov V. A., Minushkin O. N. Recommendations for the use of human placenta hydrolysate in liver diseases. Experimental and clinical gastroenterology. 2016;136(12):75-77. (in Russ.) @@Maksimov V. A., Minushkin O. N. Rekomendatsii po primeneniyu gidrolizata chelovecheskoi platsenty pri zabolevaniyakh pecheni. Eksperimental'naya i klinicheskaya gastroenterologiya. 2016;136(12):75-77.

5. Lazebnik L. B., Radchenko V. G., Seliverstov P. V., Sitkin S. I., Jadhav S. N. The contemporary understanding of liver fibrosis and approaches to treatment in patients with nonalcoholic steatohepatitis. Eksp Klin Gastroenterol. 2017;(12):98-109. (in Russ.) @@Lazebnik L. B., Radchenko V. G., Seliverstov P. V., Sitkin S. I., Dzhadkhav S. N. Sovremennoe predstavlenie o fibroze pecheni i podkhodakh k ego lecheniyu u bol'nykh nealkogol'nym steatogepatitom Eksperimental'naya i klinicheskaya gastroenterologiya. - 2017. - № 12 (148). - S. 98-109.

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3